/Companies

Shift Labs

AcquiredYC W15

Seattle, US · Founded 2012 · Delaware corporation · 6 employees · 9 known investors

Find your way into Shift Labs

Sign up to see every warm intro you have to Shift Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Shift Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.

Digital HealthHardwareHealthtechMedical DevicesUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W15)

Shift Labs was founded in 2012 by Beth Kolko.

BKBeth Kolko
Beth KolkoCEOBeth Kolko founded Shift Labs and has invested through Pioneer Fund and Pack Ventures. She is also a professor at the University of Washington.
JM
Joseph MechlinskiExecutive
KI
Koji IntlekoferCTO2013–2022Venture Partner at Pioneer

Investors · 9

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 1 of 3 rounds · 2015–2023

▶Undisclosed amountofferedMar 2023 · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph MechlinskiExecutive Officer
Minimum investment
$100K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MofferedApr 2022 · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph MechlinskiExecutive Officer, Director
Offering amount
$1.5M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJul 2015 · 26 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth KolkoExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
Minimum investment
$1K
First sale
Mar 2015
Incorporated
Corporation, Washington, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 8

Voyage BiomedicalVoyage Biomedical develops cooling technology designed to reduce brain injury in stroke patients.
SmyteSmyte provides fraud and abuse detection services to online marketplaces and social platforms, using automated classification to identify and block spam, scams, harassment, and payment fraud.
Revolve SurgicalRevolve develops a surgical robotics platform with 5mm wristed instruments and zero-footprint design for operating rooms, enabling digital surgery at costs comparable to laparoscopy. The system is designed for access across independent outpatient centers and large health networks.
Paycor, Inc.Paycor provides human capital management and payroll services for business leaders and frontline managers. The platform offers talent management, workforce management, benefits administration, and compliance tools.
NearWaveNearWave develops a handheld medical device using frequency domain near infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations for clinical and research applications. The device is positioned for use in clinical diagnostics, sports medicine, and cardiovascular health assessment.
BDBD is a global medical technology company developing devices, systems, and solutions for medication administration, diagnostics, connected care, biopharmaceutical manufacturing, and interventional procedures. The company serves healthcare providers, laboratories, and biopharmaceutical manufacturers across diagnostics, drug delivery, surgical care, and patient monitoring.
Clip HealthClip Health makes home diagnostic devices that use proprietary nanochemistry to test for infectious, metabolic, endocrine, and chronic diseases, paired with hardware and mobile apps that provide rapid results and clinical recommendations.
AudioFocusAudioFocus develops hearing aids that use machine learning and microphone array technology to isolate nearby speech while filtering distant sounds, allowing users to hear conversations in noisy environments like restaurants and social gatherings.

Companies working in the same space as Shift Labs.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$251.2K
U.S. Air ForceAir ForcePhase II2019$1.5M
U.S. Air ForceAir ForcePhase I2019$49.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 1

corporate structure
Shift Labs Inc

Frequently asked questions

What does Shift Labs do?
Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.
Who founded Shift Labs?
Shift Labs was founded by Beth Kolko in 2012.
Who are Shift Labs's investors?
Shift Labs's investors include Knockout Capital, SGH Capital, Y Combinator, GFO Companies, Great Oaks Venture Capital, Investo Capital, Lin, Bill | A10 Ventures, Tencent Holdings and 1 more.
How much funding has Shift Labs raised?
Shift Labs has disclosed $1.2M raised across 1 of its 3 known rounds.
Where is Shift Labs headquartered?
Shift Labs is headquartered in Seattle, US.